The FDA approves Inluriyo-Verzenio combo for ESR1-mutated breast cancer; EMBER-3 data double PFS, with supply chain and diagnostics implications for manufacturers.
|Articles|September 1, 2018
- Pharmaceutical Technology-09-01-2018
- Volume 2018 Supplement
- Issue 4
Pharmaceutical Technology North America, 2018 APIs, Excipients, and Manufacturing Supplement (PDF)
Click the title above to open the Pharmaceutical Technology 2018 APIs, Excipients, and Manufacturing Supplement in an interactive PDF format.
Advertisement
Articles in this issue
about 8 years ago
A Perspective on the Topical Delivery of Macromoleculesabout 8 years ago
Selecting Excipients for Liquid-Filled Hard Capsulesabout 8 years ago
Tackling Aggregation Challenges in ADC Productionabout 8 years ago
Robotics Solve Aseptic Filling Challengesabout 8 years ago
Third-Party Audits: Ensuring That Excipients Meet cGMP Requirementsabout 8 years ago
Ensuring Consistency in Content Uniformity TestingAdvertisement
Related to this article
The Leadership Summit will bring senior pharma executives together to discuss supply chain resilience, medicine security, and manufacturing capacity amid growing geopolitical fragmentation.
This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Can AI Agents Satisfy CGMP Documentation Requirements?
2
Spray Drying Capacity Signals Faster Paths for Poorly Soluble Drugs
3
PharmTech Weekly Roundup—September 18, 2026
4
Introducing the "PharmTech AI Pulse Check" Expert Video Series
5